Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
137.00Prev. Close
127.1000Volume
37600.00Value
5395600.00Fundamentals
Market Cap Cr
149.80
Price to Earnings
0.00
Price to Book Value
2.70
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
-7.56
Return on Equity %
17.86
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
83
Week
81.2
Month
73.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
141.20
PIVOT
First Resistance
146.30
Second Resistance
149.10
Third Resistance
154.20
First Support
138.40
Second Support
133.30
Third Support
130.50
Relative Strength Index
59.04
Money Flow Index
75.25
MACD
0.31
MACD Signal
-0.32
Average True Range
6.08
Average Directional Index
13.13
Rate of Change (21)
8.06
Rate of Change (125)
-14.91
Commodity Channel Index
91.7
Williams %R
-42.5
BETA
1 Month
0.53
3 Month
0.32
1 Year
0.2
3 Year
PRICE CHANGE ANALYSIS
↑ 7.73%
1 Week
Low
High
132
144
↑ 12.11%
1 Month
Low
High
115
152
↓ -5.96%
3 Months
Low
High
115
156.9
↓ -16.45%
6 Months
Low
High
115
208.45
↓ -24.51%
1 Year
Low
High
115
260
21 May 2024
Hemant Surgical Industries Ltd - 543916 - Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As On Period Ended March 31, 2024
Statement of Deviation or Variation of funds as on period ended March 31, 2024
21 May 2024
Hemant Surgical Industries Ltd - 543916 - Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.
Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.
21 May 2024
Hemant Surgical Industries Ltd - 543916 - Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.
Audited Financial Results of the Company for the half and Financial year ended on March 31, 2024.
13 May 2024
Hemant Surgical Industries Ltd - 543916 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Half And Year Ended March 31, 2024
Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 ,inter alia, to consider and approve Audited Financial Results for the half and financial year ended on March 31, 2024.
10 May 2024
Hemant Surgical Industries Ltd - 543916 - Board Meeting Intimation for Consideration Of Audited Financial Results For The Half And Financial Year Ended March 31, 2024
Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the half and Financial year ended on March 31, 2024
08 May 2024
Hemant Surgical Industries Ltd - 543916 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Non-Applicability of Annual Secretarial Compliance Report for the year ended on March 31, 2024.
29 Apr 2024
Hemant Surgical Industries Ltd - 543916 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyHemant Surgical Industries Ltd 2CIN NO.U33110MH1989PLC051133 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 4.60 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: MEENAL PATODIA Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Kaushik Hanskumar Shah Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
12 Apr 2024
Hemant Surgical Industries Ltd - 543916 - Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024
Submission of Certificate under clause 40(10) of SEBI (LODR) Regulation, 2015 for the year ended on March 31, 2024
12 Apr 2024
Hemant Surgical Industries Ltd - 543916 - Compliance Certificate Issued Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
Compliance Certificate under Reg 7(3) of SEBI (LODR) Regulations, 2015 for the financial year ended on March 31, 2024.
12 Apr 2024
Hemant Surgical Industries Ltd - 543916 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2024.
